• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov14
Vistagen Therap released FY2026 Q2 earnings on November 13 After-Market (EST), actual revenue USD 258K (forecast USD 145.8K), actual EPS USD -0.5431 (forecast USD -0.476)
00:00
Vistagen Therap released FY2026 Semi-Annual earnings on November 13 After-Market EST, actual revenue USD 502K, actual EPS USD -1.0195
00:00
Nov6
Vistagen Therap to release FY2026 Q2 earnings on November 13 After-Market EST, forecast revenue USD 145.8 K, EPS USD -0.476
00:06
Oct29
Analyst Minter Gives VistaGen a Strong Buy Rating
10:42
Aug7
Vistagen Therap released FY2026 Q1 earnings on August 7 After-Market (EST), actual revenue USD 244K (forecast USD 215.67K), actual EPS USD -0.4727 (forecast USD -0.4733)
23:00
Jul31
Vistagen Therap to release FY2026 Q1 earnings on August 7, 2025, After-Market EST, with forecasted revenue of USD 215.67 K and EPS of USD -0.4733
00:09

Schedules & Filings

Schedules
Filings
Nov13
Earning Release(EST)

FY2026 Q2 Earning Release (USD) Revenue 258 K, Net Income -19.42 M, EPS -0.5431

Aug7
Earning Release(EST)

FY2026 Q1 Earning Release (USD) Revenue 244 K, Net Income -15.1 M, EPS -0.4727

Jun17
Earning Release(EST)

FY2025 Q4 Earning Release (USD) Revenue -15 K, Net Income -13.64 M, EPS -0.432

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
MSOX
7.940
+107.85%
+4.120
YCBD
1.200
+90.17%
+0.569
THH
15.520
+57.72%
+5.680
WEED
25.325
+55.65%
+9.055
NCI
1.920
+54.84%
+0.680
CNBS
34.820
+54.57%
+12.293
MSOS
5.800
+54.26%
+2.040
CGC
1.740
+53.98%
+0.610
RYM
23.800
+47.73%
+7.690
TLRY
12.150
+44.13%
+3.720
View More